76.97
0.85%
+0.65
プレマーケット:
76.77
-0.20
-0.26%
Astrazeneca PLC (AZN) 最新ニュース
Ionis (IONS) Q1 Loss Narrower Than Expected, Sales Miss
Zacks Investment Research
Why Astrazeneca (AZN) is a Top Dividend Stock for Your Portfolio
Zacks Investment Research
The Zacks Analyst Blog Highlights AstraZeneca, Qualcomm, FedEx, American International and Baker Hughes
Zacks Investment Research
Top Analyst Reports for AstraZeneca, QUALCOMM & FedEx
Zacks Investment Research
Amgen (AMGN) Q1 Earnings Top, Stock Up on Obesity Drug Update
Zacks Investment Research
Pharma Stock Roundup: MRK, SNY, AZN, NVS' Q1 Results, Pipeline & Regulatory Updates
Zacks Investment Research
Fusion (FUSN) to Report Q1 Earnings: Here's What to Expect
Zacks Investment Research
AstraZeneca (AZN) Q1 Earnings & Sales Beat Estimates, Stock Up
Zacks Investment Research
Stocks Drop, Tech Tumbles With Meta's Weak Outlook, Q1 Stagflation Fears; Gold Miners Advance: What's Driving Markets Thursday?
Benzinga
AstraZeneca Plc (AZN) Q1 2024 Earnings Call Transcript
The Motley Fool
Merck (MRK) Q1 Earnings Top, Cancer Drug Keytruda Boosts Sales
Zacks Investment Research
Sanofi (SNY) Q1 Earnings In Line, Sales Miss Estimates, Stock Up
Zacks Investment Research
Q1 GDP Increased Lower Than Expectations
Zacks Investment Research
Is "Bad News" Still "Good News" for the Market?
Zacks Investment Research
Astrazeneca (AZN) Reports Q1 Earnings: What Key Metrics Have to Say
Zacks Investment Research
US Stocks Brace For Negative Start Amid Tech Earnings Disappointments, Caution Ahead Of Data: 'Worst Of This Two-Week Decline Is Behind Us,' Says Analyst
Benzinga
AstraZeneca (AZN) to Report Q1 Earnings: Here's What to Expect
Zacks Investment Research
Insights Into Astrazeneca (AZN) Q1: Wall Street Projections for Key Metrics
Zacks Investment Research
Can Magnificent 7 Help Script Market Turnaround? Earnings Pick Up Pace With Microsoft, Meta, Alphabet And Tesla Expected This Week
Benzinga
Astrazeneca (AZN) Could Be a Great Choice
Zacks Investment Research
Amgen/AstraZeneca's Asthma Drug Tezspire Vs. Sanofi/Regeneron's Blockbuster Dupixent - Analyst Gives His Pick
Benzinga
International Wide-Moat Stocks On Sale - The April 2024 Heat Map
Seeking Alpha
4 Exceptional Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market
The Motley Fool
AstraZeneca's (AZN) Fasenra Gets FDA Nod for Asthma in Kids
Zacks Investment Research
Pharma Stock Roundup: JNJ to Buy Shockwave Medical, Other Pipeline & Regulatory News
Zacks Investment Research
Astrazeneca (AZN) Outperforms Broader Market: What You Need to Know
Zacks Investment Research
Atossa (ATOS) Reports Positive Results From EVANGELINE Study
Zacks Investment Research
Nurix (NRIX) Up on Upbeat Initial Data From Phase I Cancer Study
Zacks Investment Research
Pfizer's (PFE) RSV Vaccine Study in Adults Under 60 Meets Goal
Zacks Investment Research
Merck (MRK) Begins Phase II/II Ovarian Cancer Study on ADC Drug (Revised)
Zacks Investment Research
AstraZeneca's (AZN) Enhertu Gets FDA Nod for Solid Tumors
Zacks Investment Research
US Manufacturing Hits 18-Month High, China's Growth Could Trigger Deflation And More: Economics Weekly Roundup
Benzinga
Astrazeneca (AZN) Advances But Underperforms Market: Key Facts
Zacks Investment Research
AstraZeneca's (AZN) Imfinzi Improves Survival in SCLC Study
Zacks Investment Research
US Labor Market Heats Up In March: Payrolls Grow By 303,000, Highest In 10 Months, Dampen June Rate Cut Hopes (UPDATED)
Benzinga
US Labor Market Heats Up In March: Payrolls Grow By 303,000, Highest In 10 Months, Dampen Rate Cut Hopes
Benzinga
Pharma Stock Roundup: AZN Voydeya Gets FDA Nod, MRK KRAS Inhibitor Enters Phase III
Zacks Investment Research
Genprex (GNPX) Expands SCLC Study of Key Candidate, Stock Up
Zacks Investment Research
The Zacks Analyst Blog Highlights Berkshire Hathaway, Procter & Gamble, Adobe, Advanced Micro Devices and AstraZeneca
Zacks Investment Research
Merck (MRK) Begins Phase II/II Ovarian Cancer Study on ADC Drug
Zacks Investment Research
Top Research Reports for Berkshire Hathaway, Procter & Gamble & Adobe
Zacks Investment Research
Are You Looking for a High-Growth Dividend Stock?
Zacks Investment Research
AstraZeneca (AZN) Dato-DXd Breast Cancer BLA Gets FDA Acceptance
Zacks Investment Research
AstraZeneca's (AZN) Rare Blood Disorder Drug Gets FDA Nod
Zacks Investment Research
Astrazeneca (AZN) Sees a More Significant Dip Than Broader Market: Some Facts to Know
Zacks Investment Research
AstraZeneca PLC (AZN) is Attracting Investor Attention: Here is What You Should Know
Zacks Investment Research
Pharma Stock Roundup: ABBV & NVO's New M&As, FDA Nod to JNJ & MRK PAH Drugs
Zacks Investment Research
Bull Market Buys: 3 Dividend Stocks to Own for the Long Run
The Motley Fool
Astrazeneca (AZN) Rises As Market Takes a Dip: Key Facts
Zacks Investment Research
Novo Nordisk (NVO) to Buy Cardior to Boost Heart Disease Pipeline
Zacks Investment Research
大文字化:
|
ボリューム (24 時間):